Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing
Market News Market Pulse Stocks News ETF News Crypto News

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

By Oculis Holding AG | December 09, 2025, 4:05 PM
OCS
+1.88%
Oculis Holding AG

ZUG, Switzerland, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.

Attachments


Mentioned In This Article

OCS
+1.88%
Oculis Holding AG

Latest News

7 min
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Oct-07
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day OCS GlobeNewswire
Oct-01
Oculis Joins the National Multiple Sclerosis Society's Campaign to End MS OCS -6.21% GlobeNewswire
Sep-30
Oculis Announces Resignation of Lionel Carnot from Board of Directors OCS GlobeNewswire
Sep-17
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Aug-24
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis OCS GlobeNewswire
Aug-14
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Aug-10
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis' Position as an Emerging Leading Neuro-Ophthalmology Company OCS GlobeNewswire
Aug-06
Oculis Reports Q2 2026 Financial Results and Provides Company Update OCS GlobeNewswire
Aug-05
Earnings To Watch: Oculis Holding AG (OCS) Reports Q2 2026 Result OCS GuruFocus.com
Aug-03
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses OCS +5.13% GlobeNewswire
Jul-08
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Jul-02
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference OCS GlobeNewswire
Jun-15
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Jun-11
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026 OCS GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)